Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome.
Ledoult E, Groh M, Meresse B, Dubois R, Trauet J, Toussaint E, Delbeke M, Hachulla E, Terriou L, De Masson A, Vasseur M, Labalette M, Launay D, Kahn JE, Lefevre G.
Ledoult E, et al. Among authors: vasseur m.
Haematologica. 2024 Feb 8. doi: 10.3324/haematol.2023.284429. Online ahead of print.
Haematologica. 2024.
PMID: 38328856
Free article.